NCT06332079View on ClinicalTrials.gov

Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

February 28, 2027

Conditions
Colorectal Cancer Metastatic
Interventions
PROCEDURE

166Holmium TARE

166Ho-TARE treatment comprises of two hospital visits: one for a work-up procedure and another for the therapy procedure, with usually a 1-2 weeks interval.

DRUG

Cetuximab

Target agent

DRUG

Panitumumab

Target agent

DRUG

5-Fluorouracil

Chemotherapy

DRUG

Bevacizumab

Target agent

DRUG

Capecitabine

Chemotherapy

Trial Locations (1)

56126

RECRUITING

Azienda Ospedaliero Universitaria Pisana, Pisa

All Listed Sponsors
lead

Gruppo Oncologico del Nord-Ovest

OTHER